产品
编 号：F036358
分子式：C21H24O10
分子量：436.41
分子式：C21H24O10
分子量：436.41
产品类型
规格
价格
是否有货
结构图
CAS No: 11023-94-2
产品详情
生物活性：
Nothofagin, a dihydrochalcone, is isolated from rooibos (Aspalathus linearis). Nothofagin downregulates NF-κB translocation through blocking calcium influx. Nothofagin has antioxidant activity and ameliorates various inflammatory responses such as the septic response and vascular inflammation.
体内研究：
Nothofagin (1 mg/kg; orally; once a day; for 7 days) significantly increases the urinary volume of both normotensive (NTR) and spontaneously hypertensive rats (SHR).Animal Model:Male Wistar normotensive and spontaneously hypertensive rats (3-4 months old)
Dosage:1 mg/kg
Administration:Orally; once a day; for 7 days
Result:Significantly increased the urinary volume of both NTR and SHR.
体外研究：
Nothofagin pre-treatment (0.1, 1, 10 μM) decreases the level of histamine release in RBL-2H3 and RPMCs cells. The production of cytokines are downregulated bynothofagin pre-treatment Nothofagin (TNF-α: 1-10 μM; IL-4: 0.1-10 μM, IL-6: 1-10 μM).Pre-treatment of DNPHSA-stimulated RBL-2H3 with Nothofagin (10 μM) markedly suppresses the phosphorylation of Lyn, Syk, and Akt.Nothofagin (30 μM; for 6 hours) results in inhibited formation of LPS-induced (100 ng/mL; 4 hours) paracellular gaps with the formation of dense F-actin rings in HUVECs. Nothofagin suppresses IgE-mediated mast cell degranulation both in vitro and in vivo.
Nothofagin, a dihydrochalcone, is isolated from rooibos (Aspalathus linearis). Nothofagin downregulates NF-κB translocation through blocking calcium influx. Nothofagin has antioxidant activity and ameliorates various inflammatory responses such as the septic response and vascular inflammation.
体内研究：
Nothofagin (1 mg/kg; orally; once a day; for 7 days) significantly increases the urinary volume of both normotensive (NTR) and spontaneously hypertensive rats (SHR).Animal Model:Male Wistar normotensive and spontaneously hypertensive rats (3-4 months old)
Dosage:1 mg/kg
Administration:Orally; once a day; for 7 days
Result:Significantly increased the urinary volume of both NTR and SHR.
体外研究：
Nothofagin pre-treatment (0.1, 1, 10 μM) decreases the level of histamine release in RBL-2H3 and RPMCs cells. The production of cytokines are downregulated bynothofagin pre-treatment Nothofagin (TNF-α: 1-10 μM; IL-4: 0.1-10 μM, IL-6: 1-10 μM).Pre-treatment of DNPHSA-stimulated RBL-2H3 with Nothofagin (10 μM) markedly suppresses the phosphorylation of Lyn, Syk, and Akt.Nothofagin (30 μM; for 6 hours) results in inhibited formation of LPS-induced (100 ng/mL; 4 hours) paracellular gaps with the formation of dense F-actin rings in HUVECs. Nothofagin suppresses IgE-mediated mast cell degranulation both in vitro and in vivo.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备